Manjula Patel, Molecular Partners AG (C); Brian B. Berger, Allergan Inc. (C), Bausch + Lomb Inc. (C), Genentech Inc. (F), GlaxoSmithKline Inc. (F, C), Molecular Partners AG (F), Pfizer Inc. (F); Jeffrey S. Heier, Alimera Sciences (F, C), Allergan Inc. (F, C), Fovea Pharmaceuticals (F, C), Genentech Inc. (F, C), Molecular Partners AG (F), Novagali Pharma (F, C), Regeneron Inc. (F, C); David M. Brown, Alcon Inc. (F, C), Alimera Inc. (F), Allergan Inc. (F, C), Genentech Inc. (F, C), Molecular Partners AG (F), Novartis Inc. (F, C), Regeneron Inc. (F, C); Peter A. Campochiaro, Alimera (C), Bristol Myers Squibb Inc. (not current) (F), Genentech Inc. (F, C), Genzyme (C), GlaxoSmithKline Inc. (F, C), LPath Inc. (F), Molecular Partners AG (F), Pfizer Inc (F), Regeneron Inc. (F); Michael T. Stumpp, Molecular Partners AG (E, P)